alexa
Reach Us +1-218-451-2974
Molecular Interplay Among A Beta, Tau And 5-Lipoxygenase: Implications For Alzheimer?s Disease Therapy | 12516
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

14th International Conference on Alzheimer s Disease & Dementia

Zurich, Switzerland

12th World Congress on Alzheimers Disease & Dementia

Budapest, Hungary
Share This Page

Molecular interplay among A beta, tau and 5-Lipoxygenase: Implications for Alzheimer?s disease therapy

International Conference on Psychology, Autism and Alzheimers Disease

Domenico Pratico

Accepted Abstracts: J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.004

Abstract
The 5-Lipoxygenase (5LO) is up regulated in Alzheimer?s disease (AD), and in vivo modulates the amyloidotic phenotype of APP transgenic mice. However, no data are available on the effects that 5LO has on synaptic function, integrity and cognition. To address this issue we used a genetic and a pharmacologic approach by generating 3xTg mice deficient for 5LO, and administering 3xTg mice which a 5LO inhibitor. Compared with controls, we found that even before the development of overt neuropathology, both animals manifested significant memory improvement, rescue of their synaptic dysfunction and amelioration of synaptic integrity. In addition, later in life these mice had a significant reduction of A? and tau pathology. Our findings support a novel functional role for 5LO in regulating synaptic plasticity and memory. They establish this protein as a pleiotropic contributor to the development of the full spectrum of the AD phenotype, making it a valid therapeutic target for the treatment of AD.
Biography
Domenico Pratico is Professor of Pharmacology, Microbiology and Immunology and member of the Center for Translational Medicine at Temple University Internationally known for his work on Alzheimer?s disease. He has authored over 195 articles, and has received many awards for his research accomplishments including the Biomedicine Investigator Award for Excellence in Scientific Research, Irvine H. Page Award for Medical Research, Neurosciences Education and Research Award, The Zenith Award from the Alzheimer?s Association, and the Dorothy Dillon Eweson Lectureship. During his 18-year academic career he has trained over 16 postdoctoral fellows, mentored more than 15 graduate students with many former trainees now heading up their own laboratories at other universities across the country
Top